Drug composition for treating infantile diarrhea and preparation method thereof
A technology for children's diarrhea and a composition, applied in the field of traditional Chinese medicine, can solve the problems of increasing patient suffering, patient side effects, weak symptomaticity and the like, and achieves the effects of low cost, high bioavailability and small dosage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0020] A pharmaceutical composition for treating infantile diarrhea, which is prepared from the following raw materials in weight ratio:
[0021] 30 parts of white lentils, 27 parts of pulsatilla, 25 parts of red peony, 25 parts of curcuma, 25 parts of dandelion,
[0022] 22 parts of radish seed, 22 parts of Atractylodes macrocephala, 20 parts of pomegranate peel, 20 parts of fungus, 18 parts of almond,
[0023] Poria cocos 18 parts, Ling Xiaohua 18 parts, licorice 15 parts, Fangfeng 15 parts, Cyperus cyperi 15 parts,
[0024] 15 parts of perilla leaves, 10 parts of dried ginger, 10 parts of purslane, 10 parts of Citrus aurantium, 10 parts of Albizia juniper,
[0025] 7 parts of Burnet, 7 parts of Chuanxiong, 5 parts of Cortex Phellodendri, 3 parts of Lycium barbarum, and 3 parts of hawthorn.
[0026] Its preparation and taking method of the pharmaceutical composition of the present invention are: take the crude drug (proportioning unit: gram) of above-mentioned parts by wei...
Embodiment 2
[0032] 1. Toxicity test
[0033] In this experiment, healthy SD rats were used, and the dose gradient of the drug prepared in Example 1 was administered orally at 0.05 mg / kg and 1.0 mg / kg. The drug was administered continuously for 30 days, and the rats were observed during the administration period and 1 week after drug withdrawal. Animal growth status, activity diet, hematology, blood biochemistry, organ tissue structure and urine routine were not significantly affected, indicating that the clinical medication is safe and reliable.
[0034] 2. Effects on castor oil-induced diarrhea model in mice
[0035] Get 60 ICR mice, half male and half male, randomly divided into model control group, Smecta group, the present invention (medicine of embodiment 1) group, the model group was given equal volume of normal saline, once a day, for three consecutive days. 40 minutes after the last administration, each animal was given 0.2ml castor oil by intragastric administration. The mice w...
Embodiment 3
[0039] A total of 103 children with acute and chronic diarrhea were tested, including 50 females and 53 males, aged between 8 months and 2 years old. The above patients were randomly divided into two groups: 52 cases in the treatment group and 51 cases in the control group;
[0040] Diagnostic criteria
[0041]According to the diagnostic criteria for infantile diarrhea in the "Practical Pediatric Diagnosis and Treatment Standards", with the pale tongue and white coating as the main basis for the type of spleen deficiency, all patients were diagnosed as infantile diarrhea.
[0042] treatment method
[0043] The treatment group took the medicine prepared in Example 1 orally, 1 g each time for <1 year old, 2 g each time for 1-2 years old, and 3 g each time for 2-3 years old, three times a day.
[0044] The control group took Smecta orally, 1g each time for <1 year old, 2g each time for 1-2 years old, 3g each time for 2-3 years old, all three times a day.
[0045] A course of t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com